Tech Company Financing Transactions
YolTech Therapeutics Funding Round
AstraZeneca and private investors participated in a $45 million Series B funding round for YolTech Therapeutics. The financing closed on 9/11/2025.
Transaction Overview
Company Name
Announced On
9/11/2025
Transaction Type
Venture Equity
Amount
$45,000,000
Round
Series B
Investors
AstraZeneca (Lead Investor)
Proceeds Purpose
The company intends to use the funds to support the advancement of YolTech's clinical programs and global strategic execution.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
12F, Building 1, No. 58 Tanzhu Road, Minhang District
Shanghai, Undisclosed
China
Shanghai, Undisclosed
China
Phone
Website
Email Address
Overview
YolTech Therapeutics is a clinical-stage in vivo gene editing company committed to pioneering the next generation of precision genetic medicines. Our approach combines innovative gene editing technologies with an advanced lipid nanoparticle (LNP) delivery system, creating a versatile platform designed to address a wide range of serious diseases. Central to our mission is the development of internal capabilities, including end-to-end manufacturing, to ensure the highest standards of quality and scalability. Our lead candidate, targeting ATTR, marks a significant milestone as China's first LNP-mediated in vivo gene editing therapy to enter clinical development. With promising early clinical outcomes, YolTech is also advancing therapies for familial hypercholesterolemia (FH) and primary hyperoxaluria type 1 (PH1). As a company dedicated to transforming the treatment landscape, YolTech continues to push the boundaries of what is possible in gene editing.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Yuxuan Wu
Browse more venture capital transactions:
Prev: 9/11/2025: Lovu Health venture capital transaction
Next: 9/11/2025: Diana Health venture capital transaction
Share this article
About Database of VC Transactions
We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from company press releases and news coverage. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs